Ragan Insider Ted Kitterman
Invidior lashes out over opioid-related fraud charges
The U.K. drug maker offers two-pronged pushback: first, that the indictment is without merit and, second, that prior owners are at fault. Investors seem not to care, as its stock plummets.
